The Impact of Treatment-Free Remission of Tasigna® for CML Patients in China – A Cost Effectiveness Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy